Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.
about
Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza PandemicOptimal Use of Vaccines for Control of Influenza A Virus in SwineRandomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskSerial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.Harnessing Local Immunity for an Effective Universal Swine Influenza VaccineSwine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.Influenza A virus infections in swine: pathogenesis and diagnosis.A human-like H1N2 influenza virus detected during an outbreak of acute respiratory disease in swine in Brazil.Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface.Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United StatesHeterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.Reassortment between Swine H3N2 and 2009 Pandemic H1N1 in the United States Resulted in Influenza A Viruses with Diverse Genetic Constellations with Variable Virulence in Pigs.Pigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.Options and obstacles for designing a universal influenza vaccineImmune and inflammatory response in pigs during acute influenza caused by H1N1 swine influenza virus.Animal models for influenza viruses: implications for universal vaccine developmentVaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model.Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.Immunohistochemical Detection of Markers for Translational Studies of Lung Disease in Pigs and HumansProtein composition of bronchoalveolar lavage fluid and airway surface liquid from newborn pigs.Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.Vaccination of rabbits with immunodominant antigens from Sarcoptes scabiei induced high levels of humoral responses and pro-inflammatory cytokines but confers limited protection.Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.Exploration of risk factors contributing to the presence of influenza A virus in swine at agricultural fairs.Principles for valid histopathologic scoring in research.Common and emerging infectious diseases in the animal shelter.Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies.Use of computational and recombinant technologies for developing novel influenza vaccines.Detection and characterization of an H4N6 avian-lineage influenza A virus in pigs in the Midwestern United States.Comparison of influenza A virus infection in high- and low-birth-weight pigs using morphometric analysis.Porcine respiratory disease complex after the introduction of H1N1/2009 influenza virus in Brazil.Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors.Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine.
P2860
Q26782795-CAB6018B-7DF9-447F-8E42-AD1D34182657Q26783503-FF43E745-F586-4E96-84A5-E2E6ACB29D11Q27330166-C67294BA-EAF0-41E2-AD4B-A93E19CBA421Q30151372-1C845AF2-8A03-4354-B291-A8936D16E1CEQ30234558-9C2DE7D5-434A-4A20-9F60-6D9C7075CB71Q30355545-5D2ADE88-8C19-49E6-A090-06482AA66922Q30357141-05ED0E72-515C-46D0-B70A-42331C556DCBQ30366645-9769970F-4319-47DF-9E92-97756A290C83Q30370471-A5560621-C0D4-4A3B-B92C-74DC0C572872Q30378432-F5E41509-DAED-4FCA-B759-E600A94FA89AQ30384443-B936160B-75EF-4BCE-8DE1-8821E451FCE3Q30386279-DC5FB415-4DDE-4065-9978-1C0D89572416Q30395259-499AB7C8-2A57-4E08-BC1A-EE7AA0F79B96Q30396157-F3CE552C-C456-475B-8887-BDD3206896FFQ30396591-32465888-FE78-448D-AD12-CAA0A9B59A83Q34102290-AB46255B-167C-4117-85E5-5D2DF584D7BCQ34235413-673F2637-16C2-40BC-95C0-43C9E5E50B50Q34809686-7BB64CC1-07BD-4A90-81B5-AFD2724AE227Q34976021-E0949A47-9B39-437D-8C1F-80341951CEF1Q36076112-27F87740-B778-41F0-B0DA-3890029BBA95Q36087562-F099D752-D8F3-4A93-A8C4-B201C96F9627Q36276647-D13F7E9B-7D7D-4636-BAA3-D6F18BF60704Q36378581-D8ACBCF2-1F80-4DBB-90CB-6D3FFD5AC474Q36723157-030D0D36-1C33-4019-A7A8-8BBEF6855AC5Q37094215-5B623612-8B09-47C8-ADDB-3A659ECB80A8Q37123473-90FAB34A-BBCB-47C6-A3D7-CE7F0A2D0C95Q37160531-02A2A1F0-1F36-4534-A994-5E4025C72976Q37197103-18DBE5A3-AF84-4574-BB47-B398D1E9A24CQ37224897-FA080F98-7FCD-43AB-AB74-2C02B6A671EFQ37554823-494E426E-3212-4875-964C-78C7B0266132Q38096305-91267744-4E60-4095-85F9-E58D12C21039Q38165151-27BEEF50-D82C-44B3-9BEE-761734D48287Q38436945-105DD1E2-FF6D-4E47-8186-F51318218E47Q38643466-C73BA074-8BB1-4DF1-A242-B6361D220CD8Q40070405-3F9F738D-6194-4D57-80C6-104F8AA27C38Q42253274-6970C3E7-0E1D-42F7-83AD-753C5F7220C3Q45324835-E9D011D2-27FA-4193-92AD-905998E301B6Q47547891-EE8BB5CA-D8F3-49B4-9404-FDE91B12EF5CQ54217589-D8342334-E95F-4FF3-B0D1-CE719D561B01Q54226450-FA2F1E94-2DCD-4029-8578-E036DE1E3189
P2860
Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Kinetics of lung lesion develo ...... (2009) A/H1N1 influenza virus.
@ast
Kinetics of lung lesion develo ...... (2009) A/H1N1 influenza virus.
@en
type
label
Kinetics of lung lesion develo ...... (2009) A/H1N1 influenza virus.
@ast
Kinetics of lung lesion develo ...... (2009) A/H1N1 influenza virus.
@en
prefLabel
Kinetics of lung lesion develo ...... (2009) A/H1N1 influenza virus.
@ast
Kinetics of lung lesion develo ...... (2009) A/H1N1 influenza virus.
@en
P2093
P2860
P356
P1433
P1476
Kinetics of lung lesion develo ...... (2009) A/H1N1 influenza virus.
@en
P2093
A L Vincent
C L Loving
J N Henningson
M E Kehrli
P C Gauger
P2860
P304
P356
10.1177/0300985812439724
P577
2012-03-28T00:00:00Z